Does ICOSAPENT Cause Hypertransaminasaemia? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Hypertransaminasaemia have been filed in association with ICOSAPENT. This represents 7.3% of all adverse event reports for ICOSAPENT.
9
Reports of Hypertransaminasaemia with ICOSAPENT
7.3%
of all ICOSAPENT reports
1
Deaths
9
Hospitalizations
How Dangerous Is Hypertransaminasaemia From ICOSAPENT?
Of the 9 reports, 1 (11.1%) resulted in death, 9 (100.0%) required hospitalization.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ICOSAPENT. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ICOSAPENT Cause?
Hepatotoxicity (36)
Drug-induced liver injury (35)
Hepatic cirrhosis (33)
Hepatic encephalopathy (33)
Hepatic necrosis (33)
Drug interaction (29)
Drug ineffective (24)
Hypertriglyceridaemia (16)
Myocardial infarction (15)
Coronary artery disease (12)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which ICOSAPENT Alternatives Have Lower Hypertransaminasaemia Risk?
ICOSAPENT vs ICOSAPENT ETHYL
ICOSAPENT vs IDARUBICIN
ICOSAPENT vs IDARUCIZUMAB
ICOSAPENT vs IDECABTAGENE VICLEUCEL
ICOSAPENT vs IDELALISIB